HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Halteren, A. G.S. Articles by Mathieu, C. Search for Related Content PubMed PubMed Citation Articles by van Halteren, A. G.S. Articles by Mathieu, C. Social Bookmarking                What's this?

Redirection of Human Autoreactive T-Cells Upon Interaction With Dendritic Cells Modulated by TX527, an Analog of 1,25 Dihydroxyvitamin D₃

¹ Department of Immunohematology and Blood Transfusion, Leids Universitair Medisch Centrum, Leiden, the Netherlands
² Laboratory for Experimental Medicine and Endocrinology (LEGENDO), Katholieke Universiteit Leuven, Leuven, Belgium
³ Department of Cell Biology and Histology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands

The active form of vitamin D₃, 1,25-dihydroxyvitamin D₃ (1,25(OH)₂D₃), is a potent immunomodulator known to affect T-cells through targeting antigen-presenting cells such as dendritic cells (DCs). We studied the effects of a novel nonhypercalcemic 1,25(OH)₂D₃ analog, TX527, on DC differentiation, maturation, and function with respect to stimulation of a committed human GAD65-specific autoreactive T-cell clone. Continuous addition of TX527 impaired interleukin (IL)-4 and granulocyte/macrophage colony-stimulating factor (GM-CSF)-driven DC differentiation as well as lipopolysaccharide (LPS) and interferon- (IFN-)-induced maturation into Th1-promoting DC (DC1), as characterized by marked changes in DC morphology and abrogation of IL-12p70 release upon CD40 ligation. Addition of TX527 during maturation did not affect DC morphology but significantly changed DC cytokine profiles. The potential of treated DCs to alter the response pattern of committed autoreactive T-cells was found to depend on the timing of TX527 exposure. Continuously TX527-treated DCs significantly inhibited T-cell proliferation and blocked IFN-, IL-10, but not IL-13 production, whereas DCs treated during maturation failed to inhibit T-cell proliferation but affected IL-10 and IFN- production. Collectively, we provide evidence that nonhypercalcemic TX527 is a potent in vitro DC modulator, yielding DCs with the potential to change cytokine responses of committed autoreactive T-cells.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Chen, G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation J. Immunol., August 1, 2007; 179(3): 1634 - 1647. [Abstract] [Full Text] [PDF]

				G. Penna, S. Amuchastegui, N. Giarratana, K. C. Daniel, M. Vulcano, S. Sozzani, and L. Adorini 1,25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells J. Immunol., January 1, 2007; 178(1): 145 - 153. [Abstract] [Full Text] [PDF]

				I. Durinovic-Bello, S. Rosinger, J. A. Olson, M. Congia, R. C. Ahmad, M. Rickert, J. Hampl, H. Kalbacher, J. W. Drijfhout, E. D. Mellins, et al. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype PNAS, August 1, 2006; 103(31): 11683 - 11688. [Abstract] [Full Text] [PDF]

				M. Delgado, E. Gonzalez-Rey, and D. Ganea The Neuropeptide Vasoactive Intestinal Peptide Generates Tolerogenic Dendritic Cells J. Immunol., December 1, 2005; 175(11): 7311 - 7324. [Abstract] [Full Text] [PDF]

				G. Penna, A. Roncari, S. Amuchastegui, K. C. Daniel, E. Berti, M. Colonna, and L. Adorini Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3 Blood, November 15, 2005; 106(10): 3490 - 3497. [Abstract] [Full Text] [PDF]

				M. C. Gauzzi, C. Purificato, K. Donato, Y. Jin, L. Wang, K. C. Daniel, A. A. Maghazachi, F. Belardelli, L. Adorini, and S. Gessani Suppressive Effect of 1{alpha},25-Dihydroxyvitamin D3 on Type I IFN-Mediated Monocyte Differentiation into Dendritic Cells: Impairment of Functional Activities and Chemotaxis J. Immunol., January 1, 2005; 174(1): 270 - 276. [Abstract] [Full Text] [PDF]

				E. VAN ETTEN, O. DARDENNE, C. GYSEMANS, L. OVERBERGH, and C. MATHIEU 1,25-Dihydroxyvitamin D3 Alters the Profile of Bone Marrow-Derived Dendritic Cells of NOD Mice Ann. N.Y. Acad. Sci., December 1, 2004; 1037(1): 186 - 192. [Abstract] [Full Text] [PDF]

				M T Abreu, V Kantorovich, E A Vasiliauskas, U Gruntmanis, R Matuk, K Daigle, S Chen, D Zehnder, Y-C Lin, H Yang, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density Gut, August 1, 2004; 53(8): 1129 - 1136. [Abstract] [Full Text] [PDF]

				A. M. Woltman and C. van Kooten Functional modulation of dendritic cells to suppress adaptive immune responses J. Leukoc. Biol., April 1, 2003; 73(4): 428 - 441. [Abstract] [Full Text] [PDF]